These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 38673907)

  • 1. Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice.
    Agnello L; Gambino CM; Ciaccio AM; Masucci A; Vassallo R; Tamburello M; Scazzone C; Lo Sasso B; Ciaccio M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
    Chudzik A; Śledzianowski A; Przybyszewski AW
    Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases.
    Baldacci F; Lista S; O'Bryant SE; Ceravolo R; Toschi N; Hampel H;
    Methods Mol Biol; 2018; 1750():139-155. PubMed ID: 29512070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.
    Abu-Rumeileh S; Steinacker P; Polischi B; Mammana A; Bartoletti-Stella A; Oeckl P; Baiardi S; Zenesini C; Huss A; Cortelli P; Capellari S; Otto M; Parchi P
    Alzheimers Res Ther; 2019 Dec; 12(1):2. PubMed ID: 31892365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies.
    Mattsson-Carlgren N; Palmqvist S; Blennow K; Hansson O
    Nat Commun; 2020 Dec; 11(1):6252. PubMed ID: 33288742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.
    Noelker C; Hampel H; Dodel R
    Mol Diagn Ther; 2011 Apr; 15(2):83-102. PubMed ID: 21623645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
    Blennow K; Biscetti L; Eusebi P; Parnetti L
    Mov Disord; 2016 Jun; 31(6):836-47. PubMed ID: 27145480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of neurodegeneration - not only Alzheimer's disease and not only cerebrospinal fluid: a guest-editor's introduction.
    Lewczuk P
    J Neural Transm (Vienna); 2012 Jul; 119(7):735-7. PubMed ID: 22664780
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
    Obrocki P; Khatun A; Ness D; Senkevich K; Hanrieder J; Capraro F; Mattsson N; Andreasson U; Portelius E; Ashton NJ; Blennow K; Schöll M; Paterson RW; Schott JM; Zetterberg H
    Alzheimers Res Ther; 2020 Feb; 12(1):20. PubMed ID: 32111242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
    Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
    Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurochemical markers of neurodegeneration in the early diagnosis of Alzheimer's disease, vascular and mixed dementia].
    Uspenskaia OV; Iakhno NN; Belushkina NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):36-40. PubMed ID: 20823828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development.
    Baldacci F; Lista S; Palermo G; Giorgi FS; Vergallo A; Hampel H
    Expert Rev Proteomics; 2019 Jul; 16(7):593-600. PubMed ID: 31195846
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
    Hu WT; Chen-Plotkin A; Arnold SE; Grossman M; Clark CM; Shaw LM; Pickering E; Kuhn M; Chen Y; McCluskey L; Elman L; Karlawish J; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
    Acta Neuropathol; 2010 Jun; 119(6):669-78. PubMed ID: 20232070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
    Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.